Is Krebs Biochemicals & stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Krebs Biochemicals & pays dividends. Last time was Saturday 1st of October 2005 where the investors holding the stock on Wednesday 14th of September 2005 were paid INR3 per share. Over the last 1 times between 2005 and 2005, Krebs Biochemicals & has paid INR3 with an average of INR3 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Krebs Biochemicals & 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR84.00, you would have made a loss of INR-2.73 per share or -3.25%
Yes, the average daily trading liquidity for Krebs Biochemicals & is INR134 306 thousand. You should therefore be able to get in and out of your positions relatively fast.
Krebs Biochemicals & has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.05, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Krebs Biochemicals & to be high [1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.